Latest Market Outlook News

Evion Group has marked a key milestone with its first expandable graphite shipment from its India joint venture, while progressing critical permitting for its flagship Maniry Graphite Project in Madagascar. The company also secured $2 million in funding to support expansion and development.

Ronin Resources has made significant strides in its La Punilla gold-silver project in Argentina, while navigating socio-political hurdles in Colombia and refining its lithium exploration efforts in Canada. The company maintains a solid cash position as it pursues new business opportunities.

Little Green Pharma reported a robust 40% revenue increase for FY25, driven by strong European sales and the strategic acquisition of Health House. The company also advanced clinical research and secured new therapy funding, positioning itself for continued growth.

Jupiter Mines reported a robust Q3 FY2025 with higher manganese production and sales at Tshipi, driving a 65% jump in EBITDA amid improved prices and reduced costs.

Hartshead Resources has submitted a revised development plan for its Anning and Somerville gas fields, featuring a superior export route via CalEnergy's Saturn Banks pipeline. Supported by a strong cash position and committed partners, the company is exploring innovative funding to optimise project economics.

Appen Limited reported a 12% revenue increase excluding Google in Q1 FY25, alongside a significant improvement in underlying EBITDA and a robust cash position, setting a positive tone for the year ahead.

Coronado Global Resources delivered March quarter production in line with plans despite Queensland rainfall, progressing key expansion projects and implementing significant cost reductions to navigate challenging metallurgical coal markets.

Blue Star Helium reports robust natural gas flow and high permeability from its Jackson 27 well in Colorado’s Galactica project, underpinning optimistic production forecasts.

Cauldron Energy reports a maiden inferred uranium resource of 11.1 million pounds at Manyingee South, boosting total Yanrey Project resources by 35%. The company also expands its footprint with six new tenements, positioning itself strongly amid a bullish uranium market.

Centuria Capital No. 2 Fund’s latest quarterly report confirms full compliance with note terms and stable financial arrangements, reassuring investors of its secure position.

Medical Developments International reported a robust Q3 FY25 with $8.9 million revenue and $1.7 million operating cashflow, driven by strong Penthrox demand and pricing. New distribution agreements in France and Switzerland position the company for further European expansion.

EBOS Group Limited announces the retirement of CEO John Cullity after a decade of strong growth, appointing Adam Hall as his successor to lead the company’s next phase of expansion.